Markets:

Overview

News

Currencies

International

Treasuries

Glaukos Corporation Common Stock (NY:GKOS)

238.28 -0.33 (-0.14%)

Delayed Quote Updated: 10:36 AM EST, Nov 3, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Glaukos Corporation Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Glaukos Announces First Patient Enrolled in Phase 2 Clinical Trial for Dry Eye Disease

January 11, 2022

From Glaukos Corporation

Via Business Wire

Glaukos’ iDose® TR Demonstrates Sustained IOP Reduction and Favorable Safety Profile Over 36 Months in Phase 2b Study

January 11, 2022

From Glaukos Corporation

Via Business Wire

The Daily Biotech Pulse: Glaukos Gets FDA Nod, Neurocrine Preannounces Soft Ingrezza Sales, 3 IPOs ↗

January 07, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hepion's Lead NASH Drug Candidate Gets The Non-Proprietary Name...

Via Benzinga

A Peek Into The Markets: US Stock Futures Higher; All Eyes On Jobs Report ↗

January 07, 2022

Pre-open movers U.S. stock futures traded higher in early pre-market trade ahead of the key jobs data for December. Investors are awaiting earnings results from Acuity Brands,...

Via Benzinga

5 Stocks To Watch For January 7, 2022 ↗

January 07, 2022

Some of the stocks that may grab investor focus today are: Wall Street expects Acuity Brands, Inc. (NYSE: AYI) to report quarterly earnings at $2.41 per share on revenue of $...

Via Benzinga

Glaukos Announces FDA 510(k) Clearance of iPRIME™

January 06, 2022

From Glaukos Corporation

Via Business Wire

Glaukos Announces Participation in the J.P. Morgan Healthcare Conference

December 29, 2021

From Glaukos Corporation

Via Business Wire

Glaukos Announces Retirement of William J. Link, Ph.D., as Chairman of the Board and Election of Thomas W. Burns as New Chairman and Mark J. Foley as Lead Independent Director

December 20, 2021

From Glaukos Corporation

Via Business Wire

Glaukos Corp (GKOS) FY 2021 Earnings Call Transcript ↗

November 30, 2021

GKOS earnings call for the period ending November 29, 2021.

Via The Motley Fool

Topics Earnings

Glaukos Announces Participation in Upcoming Investor Conferences

November 19, 2021

From Glaukos Corporation

Via Business Wire

FDA Clears Sight Sciences' Trial Of Canaloplasty Combined With Cataract Surgery To Lower Ocular Pressure ↗

November 11, 2021

The FDA has signed off Sight Sciences Inc's (NASDAQ: SGHT) clinical study to assess investigational higher volume OMNI device to perform canal viscodilation...

Via Benzinga

Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 American Academy of Ophthalmology Annual Meeting

November 11, 2021

From Glaukos Corporation

Via Business Wire

Glaukos Corp (GKOS) Q3 2021 Earnings Call Transcript ↗

November 07, 2021

GKOS earnings call for the period ending October 31, 2021.

Via The Motley Fool

Topics Earnings

Glaukos Corporation Announces Third Quarter 2021 Financial Results

November 04, 2021

From Glaukos Corporation

Via Business Wire

Why Glaukos Stock Is Soaring Today ↗

November 03, 2021

CMS' final payment rates for 2022 spurred an analyst upgrade for Glaukos.

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 03, 2021

Gainers iRhythm Technologies (NASDAQ:IRTC) stock moved upwards by 52.78% to $117.34 during Wednesday's regular session. iRhythm Technologies's stock is trading at...

Via Benzinga

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

Why Are Glaukos Shares Rallying Today? ↗

November 03, 2021

Glaukos Corporation (NYSE: GKOS) shares have gained as investors cheer the final physician payment rates and outpatient facility fees issued by the Centers for Medicare...

Via Benzinga

86 Biggest Movers From Yesterday ↗

November 04, 2021

Gainers FAT Brands Inc. (NASDAQ: FATBB) shares gained 99.2% to settle at $15.44. FAT Brands recently announced plans to acquire Fazoli’s Restaurant Chain for $130 million....

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2021 ↗

November 03, 2021

Upgrades Benchmark upgraded the previous rating for Devon Energy Corp (NYSE:

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 03, 2021

Gainers Glaukos (NYSE:GKOS) stock increased by 25.55% to $56.58 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.6 billion...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 03, 2021

Good morning, trader! We're starting the day off right with a dive into the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

25 Stocks Moving in Wednesday's Pre-Market Session ↗

November 03, 2021

Gainers Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 56.4% to $26.20 in pre-market trading on the heels of three new announcements from the company outlining strategic plans to...

Via Benzinga

Glaukos Corporation to Release Third Quarter 2021 Financial Results after Market Close on November 4

October 14, 2021

From Glaukos Corporation

Via Business Wire

Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 European Society of Cataract and Refractive Surgeons Annual Meeting

October 07, 2021

From Glaukos Corporation

Via Business Wire

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology ↗

October 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results ↗

October 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout ↗

October 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (...

Via Benzinga

Glaukos Announces Licensing Agreement with Attillaps Holdings, Inc.

September 20, 2021

From Glaukos Corporation

Via Business Wire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.